Real Time Medical Systems' $9.2 million financing tops recent funding news in Pittsburgh

Pittsburgh-based analytics company Real Time Medical Systems has secured $9.2 million in funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced Feb. 28 and financed by SunBridge Capital Management.

According to its Crunchbase profile, "Real Time Medical Systems is focused on improving resident outcomes in long term care. We believe that the keys to a facility’s clinical, operational and financial success can be found in data extracted from the residents’ clinical records. Our powerful analytics suite and clinical decision support tools deliver meaningful data empowering timely decisions for better clinical and financial outcomes."

The eight-year-old company also raised a $435,000 round in 2014.

The round brings total funding raised by Pittsburgh companies in data and analytics over the past 90 days to $12 million. The local data and analytics industry has seen 16 funding rounds over the past year, capturing a total of $40 million in venture funding.

In other local funding news, information services and analytics company Adrich announced a seed funding round on Feb. 26, financed by Sony Innovation Fund.

According to Crunchbase, "Adrich is a Pittsburgh-based company that connects brands and retailers through product usage data and analytics. Their Post Purchase Engagement Platform is comprised of two essential components: (1) smart packaging hardware (patent pending flexible labels) that adheres to any size or type of packaging and discreetly captures consumer usage data, plus (2) customized software that constantly updates consumer post purchase usage information in a dashboard that outlines your brand metrics."

Founded in 2015, the company has raised five previous rounds, including a seed round in 2018.


This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.